SN instructed patient on new medication Namenda. SN instructed patient that namenda extended-release capsules are approved for the treatment of moderate to severe Alzheimer's disease, and that the most common side effects associated with namenda treatment are headache, diarrhea, and dizziness. Understanding was verbalized